GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,647,000 | +2.0% | 37,850 | +2.2% | 0.03% | +22.2% |
| Q1 2022 | $1,614,000 | +11.3% | 37,050 | +12.6% | 0.03% | +12.5% |
| Q4 2021 | $1,450,000 | +50.7% | 32,892 | +30.7% | 0.02% | +33.3% |
| Q3 2021 | $962,000 | -12.8% | 25,171 | -9.2% | 0.02% | -10.0% |
| Q2 2021 | $1,103,000 | -16.1% | 27,719 | -24.8% | 0.02% | -23.1% |
| Q1 2021 | $1,315,000 | -3.5% | 36,850 | -0.4% | 0.03% | -10.3% |
| Q4 2020 | $1,362,000 | -2.1% | 37,016 | +0.1% | 0.03% | -12.1% |
| Q3 2020 | $1,391,000 | -10.3% | 36,969 | -2.7% | 0.03% | -23.3% |
| Q2 2020 | $1,550,000 | +99.0% | 38,010 | +84.9% | 0.04% | +72.0% |
| Q1 2020 | $779,000 | +20.6% | 20,560 | +49.6% | 0.02% | +47.1% |
| Q4 2019 | $646,000 | +71.4% | 13,740 | +55.6% | 0.02% | +54.5% |
| Q3 2019 | $377,000 | +323.6% | 8,831 | +296.9% | 0.01% | +266.7% |
| Q2 2019 | $89,000 | -49.7% | 2,225 | -47.3% | 0.00% | -40.0% |
| Q1 2019 | $177,000 | +26.4% | 4,225 | +15.6% | 0.01% | 0.0% |
| Q4 2018 | $140,000 | -20.5% | 3,654 | -16.5% | 0.01% | 0.0% |
| Q3 2018 | $176,000 | +5.4% | 4,376 | +5.7% | 0.01% | -16.7% |
| Q2 2018 | $167,000 | -5.6% | 4,141 | -8.4% | 0.01% | 0.0% |
| Q1 2018 | $177,000 | +88.3% | 4,520 | +71.0% | 0.01% | +100.0% |
| Q4 2017 | $94,000 | -50.0% | 2,644 | -42.9% | 0.00% | -57.1% |
| Q3 2017 | $188,000 | -6.0% | 4,633 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $200,000 | -4.3% | 4,633 | -6.5% | 0.01% | 0.0% |
| Q1 2017 | $209,000 | +80.2% | 4,955 | +64.1% | 0.01% | +60.0% |
| Q4 2016 | $116,000 | -46.8% | 3,019 | -40.3% | 0.01% | -44.4% |
| Q3 2016 | $218,000 | -0.5% | 5,058 | 0.0% | 0.01% | -10.0% |
| Q2 2016 | $219,000 | +16.5% | 5,058 | +9.2% | 0.01% | +25.0% |
| Q1 2016 | $188,000 | -33.3% | 4,633 | -33.8% | 0.01% | -38.5% |
| Q4 2015 | $282,000 | -6.3% | 7,003 | -10.4% | 0.01% | -13.3% |
| Q3 2015 | $301,000 | -7.7% | 7,819 | -0.1% | 0.02% | +7.1% |
| Q2 2015 | $326,000 | -9.7% | 7,823 | 0.0% | 0.01% | -17.6% |
| Q1 2015 | $361,000 | +36.7% | 7,823 | +26.4% | 0.02% | +30.8% |
| Q4 2014 | $264,000 | -7.0% | 6,188 | 0.0% | 0.01% | -7.1% |
| Q3 2014 | $284,000 | -14.2% | 6,188 | 0.0% | 0.01% | -12.5% |
| Q2 2014 | $331,000 | 0.0% | 6,188 | 0.0% | 0.02% | -5.9% |
| Q1 2014 | $331,000 | +0.3% | 6,188 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $330,000 | +6.5% | 6,188 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $310,000 | +0.3% | 6,188 | 0.0% | 0.02% | 0.0% |
| Q2 2013 | $309,000 | – | 6,188 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |